HCAR1 and neoplasm: Dual blockade of the lactate/GPR81 pathway and the PD-1/PD-L1 pathway significantly inhibits tumor growth and induces tumor regression, while increasing the number of CD8 T cells in tumor tissue and increasing IFN-γ secretion in lymph nodes (196).